Projects per year
Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit
Hepatocellular Carcinoma
Medicine & Life Sciences
Liver
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Helicobacter pylori
Medicine & Life Sciences
Stomach
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
Hepatocytes
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Projects 2018 2018
- 3 Active
DE BELLIS - MEDICINA PREVENTIVA/PREDITTIVA IN GASTROENTEROLOGIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
DE BELLIS - MEDICINA DI PRECISIONE IN GASTROENTEROLOGIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
DE BELLIS - MEDICINA PARTECIPATIVA IN GASTROENTEROLOGIA
Ricerca, U.
1/1/18 → 12/30/18
Project: Other project
Research Output 1963 2018
A Black Swan in clinical laboratory practice: the analytical error due to interferences in immunoassay methods
Clerico, A., Belloni, L., Carrozza, C., Correale, M., Dittadi, R., Dotti, C., Fortunato, A., Vignati, G., Zucchelli, G. C., Migliardi, M. & a document endorsed by the Italian Section of the European Ligand Assay Society (ELAS), Feb 23 2018, In : Clinical Chemistry and Laboratory Medicine. 56, 3, p. 397-402 6 p.Research output: Contribution to journal › Article
Clinical laboratories
Immunoassay
Quality control
Diagnostic Errors
Quality Control
Acute phase predictors of 6-month functional outcome in Italian stroke patients eligible for in-hospital rehabilitation
Franceschini, M., Fugazzaro, S., Agosti, M., Sola, C., Di Carlo, A., Cecconi, L. & Ferro, S., Jul 1 2018, In : American Journal of Physical Medicine and Rehabilitation. 97, 7, p. 467-475 9 p.Research output: Contribution to journal › Article
Rehabilitation
Stroke
Early Ambulation
Continuing Medical Education
Accreditation
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Maugeri Centre for Telehealth and Telecare (MCTT), 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.Research output: Contribution to journal › Article